Justices Won't Review Drug Exec's $1.4M Tax Penalty

By David Hansen · June 20, 2023, 6:57 PM EDT

A former pharmaceutical executive lost his last chance to reduce a $1.4 million penalty for failing to report a foreign bank account when the U.S. Supreme Court declined on Tuesday to...

To view the full article, register now.